Home › Funds › UBS Group AG › SPRY
UBS Group AG position in SPRY
ARS PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)1.94M sh
Reported value held$15.54M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 13.73K | $137.00K | New |
| Q4 2021 | 78.84K | $525.00K | Add |
| Q1 2022 | 513 | $2.00K | Reduce |
| Q2 2022 | 502 | $2.00K | Reduce |
| Q3 2022 | 12 | $0 | Reduce |
| Q1 2023 | 2.90K | $18.90K | New |
| Q4 2023 | 1.73K | $9.47K | New |
| Q1 2024 | 104.44K | $1.07M | Add |
| Q2 2024 | 64.92K | $552.49K | Reduce |
| Q3 2024 | 109.88K | $1.59M | Add |
| Q4 2024 | 1.01M | $10.68M | Add |
| Q1 2025 | 591.18K | $7.44M | Reduce |
| Q2 2025 | 866.93K | $15.13M | Add |
| Q3 2025 | 659.89K | $6.63M | Reduce |
| Q4 2025 | 2.21M | $25.76M | Add |
| Q1 2026 | 2.26M | $18.15M | Add |
| Q2 2026 | 1.94M | $15.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRY
- BlackRock Inc 5.31M sh · $42.54M · Q2 2026
- Vanguard Group 3.51M sh · $40.88M · Q4 2025
- Capital World Investors 2.75M sh · $22.07M · Q2 2026
- Millennium Management 2.52M sh · $20.19M · Q2 2026
- Geode Capital Management 1.70M sh · $13.61M · Q2 2026
- Third Point 1.00M sh · $8.01M · Q2 2026
- Citadel Advisors 566.56K sh · $4.54M · Q2 2026
- Charles Schwab Investment Management 551.42K sh · $4.42M · Q2 2026
- Northern Trust Corp 549.06K sh · $4.40M · Q2 2026
- Bank of America Corp 463.26K sh · $3.71M · Q2 2026
- Fidelity International (FIL) 455.57K sh · $3.65M · Q2 2026